Journal Publications

Project Data Sphere's success is ultimately measured by the practice-changing scientific insights discovered by the research community. We are proud to share the following list of peer-accepted publications, and we are grateful to the data providers, research scientists, and patients that make this possible.

Article Titlesort descending Journal
Outcomes of early-stage breast cancer patients treated with sequential anthracyclines–taxanes in relationship to relative dosing intensity: a secondary analysis of a randomized controlled trial Clinical and Translational Oncology
Outcomes of metastatic breast cancer patients in relationship to disease‐free interval following primary treatment of localized disease; a pooled analysis of two clinical trials The Breast Journal
Outcomes of metastatic colorectal cancer patients in relationship to prior and concurrent antibiotics use; individual patient data analysis of three clinical trials Clinical and Translational Oncology
Outcomes of Patients With Advanced Gastrointestinal Cancer in Relationship to Opioid Use: Findings From Eight Clinical Trials Journal of the National Comprehensive Cancer Network
Overcoming barriers to develop a broad access data sharing platform Journal of Clinical Oncology
Particle Swarm Optimized Gaussian Process Classifier for Treatment Discontinuation Prediction in Multicohort Metastatic Castration-Resistant Prostate Cancer Patients IEEE Journal of Biomedical and Health Informatics
Patterns of on-treatment cardiac adverse events within three clinical trials of adjuvant anthracycline-based chemotherapy Breast Cancer
Predicted sensitivity to endocrine therapy for stage II-III hormone receptor-positive and HER2-negative (HR+/HER2-) breast cancer prior to chemo-endocrine therapy Annals of Oncology
Predicting Survival of Pancreatic Cancer Patients Treated with Gemcitabine Using Longitudinal Tumour Size Data Cancer Chemotherapy and Pharmacology
Predicting survival time for metastatic castration resistant prostate cancer: An iterative imputation approach F1000 Research
Predicting toxicity-related docetaxel discontinuation and overall survival in metastatic castration-resistant prostate cancer: a pooled analysis of open phase 3 clinical trial data Prostate Cancer and Prostatic Diseases
Predicting toxicity-related docetaxel discontinuation and survival in metastatic castration-resistant prostate cancer (mCRPC) using open phase III trial data Journal of Clinical Oncology
Prediction of Overall Survival for Metastic Pancreatic Cancer: Development and Validation of a Prognostic Nomogram with Data from Open Clinical Trial and Real-World Study Cancer Medicine
Prediction of Overall Survival for Patients with Metastatic Castration-Resistant Prostate Cancer: Development of a Prognostic Model Through a Crowdsourced Challenge with Open Clinical Trial Data The Lancet Oncology

Pages